Abstract:Low-grade gliomas encompass a subgroup of cancerous glial cell growths within the central nervous system and are distinguished by their slow growth and relatively low malignant potential. Despite their less aggressive nature, these tumors can still cause significant neurological symptoms through the compression of surrounding neural and vascular structures and, in some instances, undergo malignant transformation. For these reasons, timely and appropriate evaluation and management of low-grade gliomas is critical. Medical imaging stands as a cornerstone for evaluating patients with low-grade gliomas because of its noninvasive nature and ability to provide a vast amount of information about the underlying lesion. With the growing number of neuroimaging techniques and their capabilities, there is a lack of clear guidance on which techniques to utilize for the assessment of low-grade gliomas and what their respective core use cases should be. In this literature review, the authors discuss in significant depth the available evidence pertaining to the use of advanced neuroimaging techniques in the evaluation and management of low-grade gliomas. Specifically, they review the specificity, sensitivity, accuracy, and use cases of magnetic resonance spectroscopy (MRS), perfusion MR imaging (perfusion MRI), diffusion tensor imaging (DTI), functional MRI (fMRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), as well as other emerging imaging techniques. They conclude that most of the advanced neuroimaging techniques are reliable in differentiating low- from high-grade gliomas, whereas MRS and DTI may further support molecular subclassification of the tumor. PET has been best employed for the purpose of tumor biopsy, whereas fMRI and DTI can be particularly valuable in preoperative surgical planning, as they delineate the functionally eloquent brain regions that need to be preserved during tumor resection. MRS, PET, SPECT, and perfusion MRI are best suited to monitor tumor progression, as their respective metrics closely correlate with the underlying metabolic activity of the tumor. Together, these techniques offer a vast amount of information and serve as tools for neurologists and neurosurgeons managing patients with low-grade gliomas.

Imaging Recommendations for the Diagnosis, Staging, and Management of Adult Brain Tumors

Modern Brain Tumor Imaging

Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors

Basics for Pediatric Brain Tumor Imaging: Techniques and Protocol Recommendations

The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies

Progress on the Diagnosis and Evaluation of Brain Tumors

Imaging Cancer in Neuroradiology

Neurosurgery for Brain Tumors: Update on Recent Technical Advances

Current Advances and Challenges in Radiomics of Brain Tumors

Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors

Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging

Pre- and Post-Treatment Imaging of Primary Central Nervous System Tumors in the Molecular and Genetic Era

Present challenges and surveillance of artificial intelligence in neuro-oncology

Advanced MRI imaging techniques in pediatric brain tumors

Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma

MRI Imaging for the Detection and Diagnosis of Brain Tumors

Methodologies and Challenges: Detection and Classification Techniques for Brain Tumor of Magnetic Resonance Images

Bone tumors: state-of-the-art imaging

Advanced imaging techniques and non-invasive biomarkers in pediatric brain tumors: state of the art

The use of advanced neuroimaging modalities in the evaluation of low-grade glioma in adults: a literature review

Artificial intelligence in glioma imaging: challenges and advances